BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014

Feb 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-02-14

Reporting Person: Davis George Eric (SVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-14	Common Stock	A	10500	—	Acquired	60656	Direct

Footnotes

F1: Represents minimum number of RSUs earned for satisfaction of one of the performance conditions (approval of Vimizin in the U.S. or EU prior to December 31, 2015) for performance-based RSU awards granted under the Issuer's 2006 Share Incentive Plan. The number of shares earned is subject to further adjustment as set forth in the award, based on the Total Shareholder Return (TSR) to be calculated on December 31, 2015.

F2: Although earned, these shares only vest on the filing of the Issuer's Form 10-K for the fiscal year ended December 31, 2015, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain corporate events.